Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03432858 · ClinicalTrials.gov registry record · Phase 4
Preoperative Antibiotics for Carpal Tunnel Release Surgery
A Phase 4 study of Carpal Tunnel Syndrome, sponsored by WellSpan Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT03432858: Completed Phase 4 study of Carpal Tunnel Syndrome, sponsored by WellSpan Health.
NCT03432858 is a Phase 4 study of Carpal Tunnel Syndrome that has completed, run by WellSpan Health. The registered enrollment target is 184 participants, below the 214-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03432858, a Phase 4 study of Carpal Tunnel Syndrome, has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial to determine how effective antibiotics administered prior to endoscopic carpal tunnel release surgery are in preventing surgical site infections.
Primary Outcome
Definitive diagnosis of infection of surgical site -wounds determined to be infected will be divided into superficial or deep infections and treated according to the standard of care at WellSpan health.
Conditions Studied
Interventions
- DRUG Vancomycin
- DRUG Cefazolin
- DRUG Saline Solution
Study Locations (1)
Pennsylvania
- WellSpan Surgery and Rehab Hospital - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2020-12-14 |
| Phase | Phase 4 |
What the finished NCT03432858 record still lists
NCT03432858 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 214-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Vancomycin is the first listed.
NCT03432858 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03432858 about?
NCT03432858 is a clinical study titled "Preoperative Antibiotics for Carpal Tunnel Release Surgery". This is a clinical trial to determine how effective antibiotics administered prior to endoscopic carpal tunnel release surgery are in preventing surgical site infections.
What is the current status of trial NCT03432858?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 184 participants. The study started on 2018-05-17. Estimated completion is 2020-12-14.
What conditions does trial NCT03432858 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT03432858?
The interventions under investigation include: Vancomycin (DRUG), Cefazolin (DRUG), Saline Solution (DRUG).
Who is sponsoring clinical trial NCT03432858?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03432858 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03432858's enrollment target sits among peer trials
184 5th of 21 higher than 16 of 21 other Carpal Tunnel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
RECRUITING · Phase 4
-
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
COMPLETED · Phase 4
-
Carpal Arch Space Augmentation (CASA) Clinical Trial
RECRUITING · NA
-
Ultrasound Analysis of Human Carpal Tunnel System
RECRUITING
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI